These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31174714)

  • 1. Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.
    Cao Y; Stewart K; Wish E; Artigiani E; Sorg MH
    J Subst Abuse Treat; 2019 Jun; 101():55-66. PubMed ID: 31174714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities in Access to Opioid Treatment Programs and Office-Based Buprenorphine Treatment Across the Rural-Urban and Area Deprivation Continua: A US Nationwide Small Area Analysis.
    Amiri S; McDonell MG; Denney JT; Buchwald D; Amram O
    Value Health; 2021 Feb; 24(2):188-195. PubMed ID: 33518025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: Enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky.
    Shrestha S; Lindstrom MR; Harris D; Rock P; Srinivasan S; Pustz JC; Bayly R; Stopka TJ
    J Subst Use Addict Treat; 2023 Jul; 150():209077. PubMed ID: 37211155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
    Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
    Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of methods for measuring spatial access to health care.
    Drake C; Nagy D; Nguyen T; Kraemer KL; Mair C; Wallace D; Donohue J
    Health Serv Res; 2021 Oct; 56(5):777-787. PubMed ID: 34250592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.
    Ghertner R
    Drug Alcohol Depend; 2019 Nov; 204():107527. PubMed ID: 31525570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opioid epidemic in rural northern New England: An approach to epidemiologic, policy, and legal surveillance.
    Stopka TJ; Jacque E; Kelso P; Guhn-Knight H; Nolte K; Hoskinson R; Jones A; Harding J; Drew A; VanDonsel A; Friedmann PD
    Prev Med; 2019 Nov; 128():105740. PubMed ID: 31158400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying spatial accessibility of general practitioners by applying a modified huff three-step floating catchment area (MH3SFCA) method.
    Subal J; Paal P; Krisp JM
    Int J Health Geogr; 2021 Feb; 20(1):9. PubMed ID: 33596931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nowhere to go? Examining facility acceptance levels for serving individuals using medications for opioid used disorder.
    Kepple NJ; Parker A; Whitmore S; Comtois M
    J Subst Abuse Treat; 2019 Sep; 104():42-50. PubMed ID: 31370984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urban overdose hotspots: a 12-month prospective study in Dublin ambulance services.
    Klimas J; O'Reilly M; Egan M; Tobin H; Bury G
    Am J Emerg Med; 2014 Oct; 32(10):1168-73. PubMed ID: 25154346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.
    Lister JJ; Weaver A; Ellis JD; Himle JA; Ledgerwood DM
    Am J Drug Alcohol Abuse; 2020 May; 46(3):273-288. PubMed ID: 31809217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-Assisted Opioid Treatment Prescribers in Federally Qualified Health Centers: Capacity Lags in Rural Areas.
    Jones EB
    J Rural Health; 2018 Dec; 34(1):14-22. PubMed ID: 28842930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment.
    Havens JR; Walsh SL; Korthuis PT; Fiellin DA
    Curr HIV/AIDS Rep; 2018 Aug; 15(4):315-323. PubMed ID: 29948609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geospatial Analysis of Access to Emergency Cesarean Delivery for Military and Civilian Populations in the US.
    Uribe-Leitz T; Matsas B; Dalton MK; Lutgendorf MA; Moberg E; Schoenfeld AJ; Goralnick E; Weissman JS; Hamlin L; Cooper Z; Koehlmoos TP; Jarman MP
    JAMA Netw Open; 2022 Jan; 5(1):e2142835. PubMed ID: 35006244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.
    Higgins TM; Goodman DJ; Meyer MC
    Prev Med; 2019 Nov; 128():105786. PubMed ID: 31356827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-level Spatial Access to Prehospital Care by the National Ambulance Service in Ghana.
    Tansley G; Stewart B; Zakariah A; Boateng E; Achena C; Lewis D; Mock C
    Prehosp Emerg Care; 2016; 20(6):768-775. PubMed ID: 27074588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between county-level safety net treatment access and opioid hospitalizations and mortality in New York.
    Haley SJ; Maroko AR; Wyka K; Baker MR
    J Subst Abuse Treat; 2019 May; 100():52-58. PubMed ID: 30898328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facility Attractiveness and Social Vulnerability Impacts on Spatial Accessibility to Opioid Treatment Programs in South Carolina.
    Bozorgi P; Eberth JM; Eidson JP; Porter DE
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33923748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.